Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | PGG beta-glucan |
| Trade Name | |
| Synonyms | Imprime PGG|Odetiglucan |
| Drug Descriptions |
Imprime PGG (PGG beta-glucan) binds to and promotes cytotoxicity of neutrophils bound to tumor cells via complement receptor 3 (CR3) (NCI Drug Dictionary). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C78463 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Atezolizumab + Bevacizumab + PGG beta-glucan | Atezolizumab Bevacizumab PGG beta-glucan | 0 | 1 |
| CDX-1140 + PGG beta-glucan | CDX-1140 PGG beta-glucan | 0 | 1 |
| Cetuximab + PGG beta-glucan | Cetuximab PGG beta-glucan | 0 | 1 |
| Pembrolizumab + PGG beta-glucan | PGG beta-glucan Pembrolizumab | 0 | 6 |
| PGG beta-glucan | PGG beta-glucan | 0 | 0 |